Upload
mangesh-narwadkar
View
213
Download
0
Embed Size (px)
Citation preview
7/31/2019 2 Emergent Techniologies for Early Abortions1
1/54
Emergent Technologiesfor
Early Abortions
Dr Narwadkar MangeshDr Narwadkar Mangesh
7/31/2019 2 Emergent Techniologies for Early Abortions1
2/54
Safe Abortions - Earlier the Better
Four fold rise in complications with late abortionsFour fold rise in complications with late abortions
* WHO,* WHO, Tech Report., 1997 Tech Report., 1997
16
12
8
4
4 8 12 16 20
C o m p l
i c a
t i o n
R a
t e
%
Weeks of Amenorrhea
7/31/2019 2 Emergent Techniologies for Early Abortions1
3/54
Safe emerging technologies forearly abortions
1.1. Manual Vacuum AspirationManual Vacuum Aspiration
2.2. Medical Methods of AbortionMedical Methods of Abortion
7/31/2019 2 Emergent Techniologies for Early Abortions1
4/54
Manual Vacuum Aspiration
7/31/2019 2 Emergent Techniologies for Early Abortions1
5/54
MVA Kit (Aspirator & Cannula)
7/31/2019 2 Emergent Techniologies for Early Abortions1
6/54
MVA Kit (Aspirator & Cannula)
7/31/2019 2 Emergent Techniologies for Early Abortions1
7/54
Manual Vacuum Aspiration
Evacuation of uterine contents through aEvacuation of uterine contents through acannula, attached to a hand-held vacuumcannula, attached to a hand-held vacuum
aspirator.aspirator.The pre created vacuum evacuates theThe pre created vacuum evacuates thecontents of the uterus without damaging thecontents of the uterus without damaging thelining of the uterus.lining of the uterus.
7/31/2019 2 Emergent Techniologies for Early Abortions1
8/54
Indications for MVA
Threatened abortionThreatened abortionInevitable/ Incomplete abortionInevitable/ Incomplete abortionSeptic abortionSeptic abortionMissed abortionMissed abortionBlighted ovumBlighted ovumHydatidiform moleHydatidiform moleRetained placental productsRetained placental products
Endometrial samplingEndometrial sampling
8
7/31/2019 2 Emergent Techniologies for Early Abortions1
9/54
contraindications
Ut > 12 weeksUt > 12 weeks
Acute cervicitis/PIDAcute cervicitis/PID
Multiple fibroidsMultiple fibroidsh/o bleeding disorder h/o bleeding disorder
Suspected uterine perforationSuspected uterine perforation
7/31/2019 2 Emergent Techniologies for Early Abortions1
10/54
FIGO/WHO Endorsement of MVA
Properly equipped hospitals should abandonProperly equipped hospitals should abandoncurettage and adopt the aspiration methods,curettage and adopt the aspiration methods,selecting Manual Vacuum Evacuation and or selecting Manual Vacuum Evacuation and or Electric AspirationElectric Aspiration
MVA is an essential basic procedure at FirstMVA is an essential basic procedure at FirstReferral Unit level.Referral Unit level.
7/31/2019 2 Emergent Techniologies for Early Abortions1
11/54
Vacuum Aspiration and D&C
Lesser incidence of haemorrhage, cervicalLesser incidence of haemorrhage, cervicalinjury, lacerations, uterine perforationinjury, lacerations, uterine perforation
Less dilatation required and hence less painfulLess dilatation required and hence less painful
and lesser chances of vagal reactionsand lesser chances of vagal reactionsLess pain medication and anaesthesiaLess pain medication and anaesthesia
Less hospital stayLess hospital stay
No major O.T. set up required No major O.T. set up required
7/31/2019 2 Emergent Techniologies for Early Abortions1
12/54
MVA and EVA
Equivalent high levels of effectiveness and lowEquivalent high levels of effectiveness and lowcomplication rates.complication rates.Pressure created is EQUAL in bothPressure created is EQUAL in both
But with MVA But with MVA No electricity required No electricity requiredSafe in accidental perforationsSafe in accidental perforationsIntact gestation sac in early pregnancyIntact gestation sac in early pregnancyterminationtermination
7/31/2019 2 Emergent Techniologies for Early Abortions1
13/54
MVA ProcedureMVA Procedure
7/31/2019 2 Emergent Techniologies for Early Abortions1
14/54
Cx ripening
Commnly used agentCommnly used agent
Tab misoprost 400 microgram 3-4 hoursTab misoprost 400 microgram 3-4 hours
prior,vaginally prior,vaginallyProstodine 45 min prior I/MProstodine 45 min prior I/M
7/31/2019 2 Emergent Techniologies for Early Abortions1
15/54
Evacuating uterine contents
Dilate the cervix withcannulae of increasing sizes tillappropriate number is reached,after taking appropriate paincontrol measures
Connect the cannula to theaspirator
Move the cannula back and
forth gently and slowly, rotatingthe cannula and the syringe atthe same time
15
7/31/2019 2 Emergent Techniologies for Early Abortions1
16/54
Cannula selection
Depends upon uterine size, period of gestation,Depends upon uterine size, period of gestation,amount of dilatation required to aspirate pocamount of dilatation required to aspirate poc
Important to have appropriate cannula (retainedImportant to have appropriate cannula (retained products or loss of suction) products or loss of suction)
4-6 weeks LMP-----4-7mm cannula4-6 weeks LMP-----4-7mm cannula
7-9 weeks LMP------5-10mm cannula7-9 weeks LMP------5-10mm cannula
9-12 weeks LMP-----8-12 mm cannula9-12 weeks LMP-----8-12 mm cannula
7/31/2019 2 Emergent Techniologies for Early Abortions1
17/54
Pain managementThe three major sources of discomfort and pain
during uterine evacuation with MVA are anxiety,cervical dilation and uterine cramping.Verbal reassurance and respectful, supportive care by
staff throughout the procedure helps to reduce anxietyand decrease pain, and should be a standard part of abortion care.Pain and discomfort during an MVA procedure ca be
reduced using a combination of verbal support oralmedications, Para cervical block and gentle clinicaltechnique.
7/31/2019 2 Emergent Techniologies for Early Abortions1
18/54
Signs that the uterus is empty
Red or pink foam without tissue passingthrough cannula.
Gritty sensation over surface of uterus.Cervix gripping over the cannula.Uterus contracting around cannula. Increased
uterine cramping.
7/31/2019 2 Emergent Techniologies for Early Abortions1
19/54
Inspecting the tissue 19
Strain and Inspectthe evacuated
tissue
7/31/2019 2 Emergent Techniologies for Early Abortions1
20/54
No visible POC, a lower quantity of tissue thanexpected or an inconclusive tissue sample may
indicate incomplete abortion, completedspontaneous abortion, failed abortion, suspectedectopic pregnancy or anatomical anomaly.Technical problems that can occur with the
instrument during an MVA procedure include a fullaspirator, a cannula that is clogged or withdrawn
prematurely, or a loss of vacuum due to incorrect
assembly.
7/31/2019 2 Emergent Techniologies for Early Abortions1
21/54
Post procedure care/follow up care
Physical monitoring:Emotional support:
Contraceptive counseling:Addressing other health issues: anemia,reproductive-tract infections (RTIs, HIV, violence, ,cancer screening.
7/31/2019 2 Emergent Techniologies for Early Abortions1
22/54
Post procedure care/follow up care
Providing discharge instructions.Pain management: Analgesics, NSAID.
Provision of antibiotics: Research has shown thatroutinely providing antibiotics to womenundergoing MVA reduces infection.Scheduling follow-up care within one week.
7/31/2019 2 Emergent Techniologies for Early Abortions1
23/54
Sterilizing
Agent
MVA Plus Aspirator and Easy Grip
Cannulae can be: stetrilized by Autoclaving (121Autoclaving (121
C for 30 minutes) or soaking inC for 30 minutes) or soaking inGluteraldehyde for 10 hrsGluteraldehyde for 10 hrs
OR OR High level disinfected by boilingHigh level disinfected by boiling
for 20 minsfor 20 mins or soaking inor soaking inGluteraldehyde or chlorineGluteraldehyde or chlorinesolution for 20 mins.solution for 20 mins.
Sterilization / High Level Disinfection
7/31/2019 2 Emergent Techniologies for Early Abortions1
24/54
To sum up - MVA
MVA is an effective surgical method for terminationMVA is an effective surgical method for terminationof pregnancy up to 12 weeks.of pregnancy up to 12 weeks.
Increases access and decreases costs as it is OPDIncreases access and decreases costs as it is OPD procedure procedure
Reduces complication risks and time of procedure asReduces complication risks and time of procedure asit is done under local anaesthesiait is done under local anaesthesia
Easy to process and handleEasy to process and handle
Improves patient provider rapportImproves patient provider rapportAllows immediate identification of POCAllows immediate identification of POC
Excellent backup for failed medical abortionExcellent backup for failed medical abortion
7/31/2019 2 Emergent Techniologies for Early Abortions1
25/54
Medical Methods of Abortion
7/31/2019 2 Emergent Techniologies for Early Abortions1
26/54
What is Medical Methods of Abortion?
Medical abortion is a non surgical, non invasiveMedical abortion is a non surgical, non invasivemethod of termination of pregnancy bymethod of termination of pregnancy bycombination of drugs.combination of drugs.
7/31/2019 2 Emergent Techniologies for Early Abortions1
27/54
Medical Methods of Abortion
Approved in 30 countriesApproved in 30 countries
Available for early pregnancy up to 63 daysAvailable for early pregnancy up to 63 days
High success rate 93-95%High success rate 93-95%
It takes 8-12 days for the complete processIt takes 8-12 days for the complete process
Requires minimum 3 visitsRequires minimum 3 visits
Requires follow up to ensure completion of abortionRequires follow up to ensure completion of abortion
7/31/2019 2 Emergent Techniologies for Early Abortions1
28/54
Why women like Medical Methods of Abortion ?
No admission required No admission required
No fear of surgery No fear of surgery
The method is convenientThe method is convenient
It enables the woman to look after her home or jobIt enables the woman to look after her home or jobwithout a break without a break
(Population Council, KEM Hospital Pune 1990-1993)
C l d d
7/31/2019 2 Emergent Techniologies for Early Abortions1
29/54
Commonly used drugs
Mifepristone (RU 486)Mifepristone (RU 486)
invented in 1980initials of pharmaceutical company Roussel-Uclaf 486 is a random laboratory serial number.
MisoprostolMisoprostol
Combinations of the two drugs has a high success rateCombinations of the two drugs has a high success rate
Both the drugs have been approved for use in early Both the drugs have been approved for use in early
pregnancy termination in India pregnancy termination in India
7/31/2019 2 Emergent Techniologies for Early Abortions1
30/54
Mifepristone RU486Antiprogesterone compound that blocks Progesterone receptor Antiprogesterone compound that blocks Progesterone receptor sites in endometrium, decidua and dislodges the fertilized egg.sites in endometrium, decidua and dislodges the fertilized egg.
Available as 200 mg TabAvailable as 200 mg Tabmore effective in early pregnancy when progesterone is
present in lower concentrations due to limited production by
corpus luteum.When used alone complete abortion rate is 75%When used alone complete abortion rate is 75%
When used with Misoprostol complete abortion rate is 93-95%When used with Misoprostol complete abortion rate is 93-95%
Now available in India since April 2002 (Mifegest, Mifeprin, Now available in India since April 2002 (Mifegest, Mifeprin,MTPill, Mifyron etc)MTPill, Mifyron etc)
7/31/2019 2 Emergent Techniologies for Early Abortions1
31/54
Side Effects of Mifepristone
Serious S/E are rare, however the woman may experienceSerious S/E are rare, however the woman may experience
Nausea Nausea
VomitingVomiting
FatigueFatigue
DiarrhoeaDiarrhoea
7/31/2019 2 Emergent Techniologies for Early Abortions1
32/54
Misoprostol
PGE1 analoguePGE1 analogue
Most commonly used drug for medical methods of Most commonly used drug for medical methods of abortionabortion
FDA Approved for prevention of gastric ulcer FDA Approved for prevention of gastric ulcer Effective route are oral/vaginal/sublingual/buccalEffective route are oral/vaginal/sublingual/buccal
Available as 200 micrograms tabletAvailable as 200 micrograms tablet
Available as Cytotec, Zitotec, Cytolog, Misogon etcAvailable as Cytotec, Zitotec, Cytolog, Misogon etc
7/31/2019 2 Emergent Techniologies for Early Abortions1
33/54
Advantages of Misoprostol
Low costLow cost
Stable at room temperatureStable at room temperature
Effective by different routesEffective by different routes
7/31/2019 2 Emergent Techniologies for Early Abortions1
34/54
Side effects of Misoprostol
Nausea Nausea
VomitingVomiting
Associated with congenital anomalies, if pregnancyAssociated with congenital anomalies, if pregnancycontinuescontinues
7/31/2019 2 Emergent Techniologies for Early Abortions1
35/54
Medical Methods of Abortion& MTP Act
It can be provided only by MTP certified providers and comesIt can be provided only by MTP certified providers and comesunder the purview of MTP Act.under the purview of MTP Act.MMA upto 7 weeks of gestation can be provided from approvedsites as well as non-approved clinics with referral linkage to
approved MTP site. The law requires that a certificate of accessto a registered place (i.e. showing that a referral link has beenestablished) from the owner of the approved site must bedisplayed in the clinic where MMA is being provided.
MMA upto 63 days (9 weeks) can be provided only from theapproved sites.
Eligibility of the woman
7/31/2019 2 Emergent Techniologies for Early Abortions1
36/54
g yOption of medical methods of abortion should begiven to all women coming to a health facilityseeking termination of pregnancy up to 9 weeks of gestation
No medical contraindication.
Frame of mind of the woman, i.e.Acceptability of minimum three visitsAbility to understand the instructions
Agrees for vacuum aspiration procedure, if failure or excessive bleeding occurs.
Eligibility of the woman
7/31/2019 2 Emergent Techniologies for Early Abortions1
37/54
g y
Support from family or others.
Permission of guardian in case of minor as per MTPAct 1971.Easy access to appropriate health care facility during
emergency.
Contraindications
7/31/2019 2 Emergent Techniologies for Early Abortions1
38/54
Contraindicationsfor Medical Methods of Abortion
Undiagnosed adnexal massUndiagnosed adnexal massConfirmed or suspected ectopic pregnancyConfirmed or suspected ectopic pregnancyIUCD in situIUCD in situChronic Adrenal failureChronic Adrenal failure
Concurrent long term corticosteroid therapyConcurrent long term corticosteroid therapyInherited PorphyriasInherited Porphyrias
No access to medical facilities in case of emergency No access to medical facilities in case of emergencyuncontrolled high blood pressure, diabetes, certain heart or uncontrolled high blood pressure, diabetes, certain heart or
blood vessel diseases, severe liver, kidney or lung disease, or blood vessel diseases, severe liver, kidney or lung disease, or an uncontrolled seizure disorder an uncontrolled seizure disorder
7/31/2019 2 Emergent Techniologies for Early Abortions1
39/54
SCARRED UTERUS
a uterine scar is not a contraindicationfor first trimester misoprostol induction,
but that the risk may increase withincreasing gestational age, particularly inthe late second trimester
7/31/2019 2 Emergent Techniologies for Early Abortions1
40/54
Investigations (Recommended)Haemoglobin.Routine Urine Examination.ABO Rh.
Investigations (Optional) Ultrasound if:She is unsure of LMP.She has irregular periods.Uterine size and menstrual dates do not match.There is suspicion of ectopic / fibroid during P/Vexamination.
7/31/2019 2 Emergent Techniologies for Early Abortions1
41/54
Protocol for Medical Methods of Abortion
First visit ( Day 1) Mifepristone -First visit ( Day 1) Mifepristone - 200mg given200mg givenorally, after ruling out contraindications.orally, after ruling out contraindications.
Second visit ( Day 3) Misoprostol 400/800Second visit ( Day 3) Misoprostol 400/800microgms vaginally/orally and kept at the clinicmicrogms vaginally/orally and kept at the clinicfor 4 hoursfor 4 hours
Third visit (Day 15) Follow up Third visit (Day 15) Follow up to determine if to determine if complete abortion has occurredcomplete abortion has occurred
7/31/2019 2 Emergent Techniologies for Early Abortions1
42/54
h d h h
7/31/2019 2 Emergent Techniologies for Early Abortions1
43/54
Recent research studies have shownthat allowing women to takemisoprostol either vaginally or orallyat home is safe, effective andacceptable to women. However Government of India recommends thatmisoprostol be administered at theclinic and the woman observed for atleast four hours.
f f
7/31/2019 2 Emergent Techniologies for Early Abortions1
44/54
Outcome of Medical Methods of AbortionParity is not a major factor affecting the outcomeParity is not a major factor affecting the outcome
Lesser the period of gestation, better the resultsLesser the period of gestation, better the resultsCabezas E, Int J Gynaecol Obstet 1999;63 (suppl 1):S.:1416.Cabezas E, Int J Gynaecol Obstet 1999;63 (suppl 1):S.:1416.
Most women abort within 4 hrs of Misoprostol administrationMost women abort within 4 hrs of Misoprostol administration
Of the rest:Of the rest:30% abort within next 24 hrs30% abort within next 24 hrs
65% abort within next 5 days65% abort within next 5 daysHeaviest bleeding lasts 1 4 hours that coincides with the expulsion
of POC. Mean period for bleeding is 8 13 days)The incidence of endometritis following medical abortion is lower
than after surgical abortion
Day 3-15
7/31/2019 2 Emergent Techniologies for Early Abortions1
45/54
Day 3 15She should preferably avoid going out of station
till the third visit.She should report if there is no bleeding even 24
hrs. after taking misoprostol. This may be rare, butthe doctor should consider following possibilities:Rule out ectopic pregnancy and confirm anintrauterine pregnancy.The drug may not have worked and / or more tie is
needed; repeating the dose may be an option.
Third visit (Day 15)
7/31/2019 2 Emergent Techniologies for Early Abortions1
46/54
( y )What to do
Pelvic examination to confirm completion of abortionUSG if examination does not confirmDebris in the uterus without a gestational sac, pain,
fever, or excessive vaginal bleeding does notusually require interventionAntibiotics: These are not generally prescribedroutinely but should be given to a woman showing /
susceptible to infection.She should report back if there are no periodswithin 6 weeks of completion of the abortion
7/31/2019 2 Emergent Techniologies for Early Abortions1
47/54
Failure of the method requiring surgicalintervention
Incomplete abortion 3 - 5%Incomplete abortion 3 - 5%
Continuation of pregnancy - 1 -2%Continuation of pregnancy - 1 -2%
Excessive bleeding - 0.2 2%Excessive bleeding - 0.2 2%(soaking 2 or more maxi pads per hour for 2 hours
continuously.)
Contraception after abortion.d h
7/31/2019 2 Emergent Techniologies for Early Abortions1
48/54
Oral pills can be started on 3 rd or 15 th day of the protocol on confirmation of completion of abortion
process.IUCD can be inserted on day 15 provided the
presence of infection is ruled out.
Condom can be used as soon as she resumes sexualactivity after abortion.( It is advised to abstain from sex until theabortion process is complete.. If there is sexual activity after taking thedrugs and before the abortion, it is advised that condom / barrier be used to
prevent infection.)
Contraception after abortion..b l l b d f f l
7/31/2019 2 Emergent Techniologies for Early Abortions1
49/54
Tubal ligation can be done after first cycle. However if desirous of concurrent tubal ligation, surgical method
of abortion is preferred.Injectables can be given on the 3 rd or 15 th day, after
confirming the completion of the process.
Vasectomy, if chosen, can be done independent of the procedure.
An acceptability .If f b i i d 42 f i
7/31/2019 2 Emergent Techniologies for Early Abortions1
50/54
If a future abortion was required, 42 percent of patientswho underwent a surgical abortion would opt for a
medical abortion; in contrast, only 9 percent of womenwho received medical abortion would prefer a surgicalabortion . However, others have reported greater satisfaction with surgical abortion.
Medical abortion becomes more painful and lesseffective in women with gestations over 50 days,particularly in those using oral misoprostol . Therefore,
these women are likely to find vacuum extraction moreacceptable
Medical Abortion and the Risk of Subsequent
http://www.uptodate.com/contents/misoprostol-drug-information?source=see_linkhttp://www.uptodate.com/contents/misoprostol-drug-information?source=see_link7/31/2019 2 Emergent Techniologies for Early Abortions1
51/54
Adverse Pregnancy Outcomes
No evidence that a previous medical abortion,as compared with a previous surgical abortion,increases the risk of spontaneous abortion,ectopic pregnancy, pre- term birth, or low birthweight.
Jasveer Virk, M.S., M.P.H., Jun Zhang, Ph.D., M.D., and Jrn Olsen, M.D., Ph.D. N Engl JMed 2007;357:648-53
7/31/2019 2 Emergent Techniologies for Early Abortions1
52/54
Teratogenic effects on fetus in c/o failure of Teratogenic effects on fetus in c/o failure of medical abortion e.g. Mobius syndrome -medical abortion e.g. Mobius syndrome -congenital facial paralysis with or without limbcongenital facial paralysis with or without limbdefect, cranial nerve defect.defect, cranial nerve defect.
Because of a potential teratogenic risk, surgicalabortion is recommended in cases of failed
pregnancy termination
7/31/2019 2 Emergent Techniologies for Early Abortions1
53/54
To sum up Medical Methods of Abortion
Medical methods of termination of pregnancy haveMedical methods of termination of pregnancy haveincreased the choices for women and doctorsincreased the choices for women and doctors
Effective counseling increases the chances of success of Effective counseling increases the chances of success of medical methods of abortionmedical methods of abortion
Medical methods of abortion can go a long way inMedical methods of abortion can go a long way in
increasing access to Safe Abortionsincreasing access to Safe Abortions
7/31/2019 2 Emergent Techniologies for Early Abortions1
54/54